Literature DB >> 19846234

Validity of real time ultrasound in the diagnosis of hepatic steatosis: a prospective study.

Srinivasan Dasarathy1, Jaividhya Dasarathy, Amer Khiyami, Rajesh Joseph, Rocio Lopez, Arthur J McCullough.   

Abstract

BACKGROUND/AIMS: Ultrasound is used to screen for hepatic steatosis, the most common liver disease in the United States. However, few studies have prospectively evaluated the accuracy of ultrasound to diagnose hepatic steatosis. Therefore, a double blinded prospective study was performed in consecutive patients undergoing liver biopsy to evaluate the accuracy of ultrasound to diagnose hepatic steatosis.
METHODS: Real time ultrasound was performed just prior to the biopsy by a single investigator masked to the clinical diagnosis. The liver biopsy was reviewed by a pathologist masked to the clinical indication or sonographic findings.
RESULTS: Of 73 consecutive patients studied, macrovesicular steatosis of any severity on biopsy was found in 46 (63%) and micro vesicular fat found in 51 (69.9%). The overall impression of the sonographer for the presence of macrovesicular hepatic steatosis of any degree had a sensitivity of 60.9% and a specificity of 100%. The sensitivity increased to 100% and the specificity to 90% when there was > or =20% of fat. The zonular distribution of the fat did not alter the diagnostic accuracy of ultrasound. Ultrasound had a poor yield in the diagnosis of microvesicular fat with an overall sensitivity of 43% and a specificity of 73%. The combination of increased echogenicity and portal vein blurring on ultrasound had the greatest sensitivity in the diagnosis of hepatic steatosis.
CONCLUSION: Real time ultrasound using a combination of sonographic findings has a high specificity but underestimates the prevalence of hepatic steatosis when there is<20% fat.

Entities:  

Mesh:

Year:  2009        PMID: 19846234      PMCID: PMC6136148          DOI: 10.1016/j.jhep.2009.09.001

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  31 in total

1.  Assessing diagnostic and screening tests: Part 2. How to use the research literature on diagnosis.

Authors:  R Gilbert; S Logan; V A Moyer; E J Elliott
Journal:  West J Med       Date:  2001-07

2.  Assessing diagnostic and screening tests: Part 1. Concepts.

Authors:  R Gilbert; S Logan; V A Moyer; E J Elliott
Journal:  West J Med       Date:  2001-06

3.  Paradoxical lack of ultrasound attenuation with gross fatty change in the liver.

Authors:  R J Davies; S H Saverymuttu; M Fallowfield; A E Joseph
Journal:  Clin Radiol       Date:  1991-06       Impact factor: 2.350

4.  Quantitative estimation of attenuation in ultrasound video images: correlation with histology in diffuse liver disease.

Authors:  M Graif; M Yanuka; M Baraz; A Blank; M Moshkovitz; A Kessler; T Gilat; J Weiss; E Walach; P Amazeen; C S Irving
Journal:  Invest Radiol       Date:  2000-05       Impact factor: 6.016

5.  Ultrasound examination in diffuse liver disease. Clinical significance of enlarged lymph nodes in the hepato-duodenal ligament.

Authors:  L Forsberg; C H Florén; E Hederström; H Prytz
Journal:  Acta Radiol       Date:  1987 May-Jun       Impact factor: 1.990

6.  Magnetic resonance imaging of parenchymal liver disease: a comparison with ultrasound, radionuclide scintigraphy and X-ray computed tomography. The Clinical NMR Group.

Authors: 
Journal:  Clin Radiol       Date:  1987-09       Impact factor: 2.350

7.  The accuracy of ultrasound in the detection of fatty infiltration of the liver.

Authors:  K J Foster; K C Dewbury; A H Griffith; R Wright
Journal:  Br J Radiol       Date:  1980-05       Impact factor: 3.039

Review 8.  Non-alcoholic fatty liver disease, obesity and other illnesses.

Authors:  Giovanni Tarantino
Journal:  Clin Invest Med       Date:  2008-10-01       Impact factor: 0.825

9.  Fatty liver disease in severe obese patients: diagnostic value of abdominal ultrasound.

Authors:  Alessandro de Moura Almeida; Helma Pinchemel Cotrim; Daniel Batista Valente Barbosa; Luciana Gordilho Matteoni de Athayde; Adimeia Souza Santos; Almir Galvão Vieira Bitencourt; Luiz Antonio Rodrigues de Freitas; Adriano Rios; Erivaldo Alves
Journal:  World J Gastroenterol       Date:  2008-03-07       Impact factor: 5.742

10.  The accuracy of the report of hepatic steatosis on ultrasonography in patients infected with hepatitis C in a clinical setting: a retrospective observational study.

Authors:  Matthew J Hepburn; Jeffrey A Vos; Eric P Fillman; Eric J Lawitz
Journal:  BMC Gastroenterol       Date:  2005-04-13       Impact factor: 3.067

View more
  166 in total

1.  Controlled attenuation parameter: A measure of hepatic steatosis in patients with cystic fibrosis.

Authors:  Razan M Bader; Maureen M Jonas; Paul D Mitchell; Shanna Wiggins; Christine K Lee
Journal:  J Cyst Fibros       Date:  2018-12-01       Impact factor: 5.482

2.  Sonographic assessment of fatty liver: intraobserver and interobserver variability.

Authors:  Mustafa Cengiz; Senem Sentürk; Bulent Cetin; Aylin Hasanefendioğlu Bayrak; Senem Uysal Bilek
Journal:  Int J Clin Exp Med       Date:  2014-12-15

3.  A Pilot Comparative Study of Quantitative Ultrasound, Conventional Ultrasound, and MRI for Predicting Histology-Determined Steatosis Grade in Adult Nonalcoholic Fatty Liver Disease.

Authors:  Jeremy S Paige; Gregory S Bernstein; Elhamy Heba; Eduardo A C Costa; Marilia Fereirra; Tanya Wolfson; Anthony C Gamst; Mark A Valasek; Grace Y Lin; Aiguo Han; John W Erdman; William D O'Brien; Michael P Andre; Rohit Loomba; Claude B Sirlin
Journal:  AJR Am J Roentgenol       Date:  2017-03-07       Impact factor: 3.959

Review 4.  The Riddle of Nonalcoholic Fatty Liver Disease: Progression From Nonalcoholic Fatty Liver to Nonalcoholic Steatohepatitis.

Authors:  Mithun Sharma; Shasikala Mitnala; Ravi K Vishnubhotla; Rathin Mukherjee; Duvvur N Reddy; Padaki N Rao
Journal:  J Clin Exp Hepatol       Date:  2015-02-16

5.  Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis.

Authors:  Jens-Peter Kühn; Diego Hernando; Birger Mensel; Paul C Krüger; Till Ittermann; Julia Mayerle; Norbert Hosten; Scott B Reeder
Journal:  J Magn Reson Imaging       Date:  2013-10-10       Impact factor: 4.813

6.  Elevated serum uric acid levels are associated with non-alcoholic fatty liver disease independently of metabolic syndrome features in the United States: Liver ultrasound data from the National Health and Nutrition Examination Survey.

Authors:  Jeffrey C Sirota; Kim McFann; Giovanni Targher; Richard J Johnson; Michel Chonchol; Diana I Jalal
Journal:  Metabolism       Date:  2012-10-02       Impact factor: 8.694

7.  Double-blind randomized placebo-controlled clinical trial of omega 3 fatty acids for the treatment of diabetic patients with nonalcoholic steatohepatitis.

Authors:  Srinivasan Dasarathy; Jaividhya Dasarathy; Amer Khiyami; Lisa Yerian; Carol Hawkins; Ruth Sargent; Arthur J McCullough
Journal:  J Clin Gastroenterol       Date:  2015-02       Impact factor: 3.062

Review 8.  Noninvasive imaging assessment of non-alcoholic fatty liver disease: focus on liver scintigraphy.

Authors:  Cristiane Valle Tovo; Angelo Zambam de Mattos; Gabriela Perdomo Coral; Fernanda Schild Branco; Eiji Suwa; Angelo Alves de Mattos
Journal:  World J Gastroenterol       Date:  2015-04-21       Impact factor: 5.742

9.  Ex vivo study of quantitative ultrasound parameters in fatty rabbit livers.

Authors:  Goutam Ghoshal; Roberto J Lavarello; Jeremy P Kemmerer; Rita J Miller; Michael L Oelze
Journal:  Ultrasound Med Biol       Date:  2012-10-11       Impact factor: 2.998

10.  The diagnostic accuracy of US, CT, MRI and 1H-MRS for the evaluation of hepatic steatosis compared with liver biopsy: a meta-analysis.

Authors:  Anneloes E Bohte; Jochem R van Werven; Shandra Bipat; Jaap Stoker
Journal:  Eur Radiol       Date:  2010-07-31       Impact factor: 5.315

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.